Benzodiazepine prescribing practices for homeless veterans with mental illness

Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine prescribing for this population has not been examined.

Risk adjusted net present value: What is the current valuation of Cullinan Therapeutics’s CLN-619?

CLN-619 is a monoclonal antibody commercialized by Cullinan Therapeutics, with a leading Phase I program in Ovarian Cancer;Cervical Cancer;Endometrial Cancer.

December 14, 2024

FDA approves Journey Medical’s rosacea treatment Emrosi – Pharmaceutical Technology

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved

November 5, 2024

Texas AG accuses Pfizer of ‘intentionally’ overstating Covid-19 vaccine effectiveness

The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” and “intentionally” misrepresenting the effectiveness of its Covid-19 vaccine and attempting to censor

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.